Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...

Markets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downsid...

Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...

Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providin...

Contrary to popular belief, excessive thirst and urination might signal health issues, not peak kidney function. Dr. Priyam Bordoloi explai...

The Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...

A woman's wedding ring and shoe size grew significantly without weight change. This unusual symptom pointed to a serious condition. Dr. Sud...

The Supreme Court has asked the Centre and the Drug Controller General of India to respond to Micro Labs' appeal against a ban on two fixed...

Cipla has launched Yurpeak, a new injectable medication for obesity and type-2 diabetes. This one-weekly therapy, tirzepatide, is now avail...

The prevalence of Type 2 Diabetes Mellitus (T2DM) is rising globally, increasing cardiovascular disease (CVD) risk. Effective management st...

Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This move aims to pr...

Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patient...

The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Empagliflozin tablets, in...

On World Diabetes Day, here's a list of new medications that will make life simpler for diabetics.

The company has been granted marketing approval from the Mexican regulatory authority COFEPRIS to commercialise Lipaglyn in Mexico, Zydus s...

The study published in the Global Journal of Medicine and Public Health, showed that 11.69 per cent women in West Bengal, suffered from ges...